Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|October 2, 2003
Correlation of pupil sizes measured with a mesopic infrared pupillometer and a photopic topographerLaura M Periman, Renato Ambrosio, Devin A Harrison, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 6, 2020
Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial TearsAlice T Epitropoulos, Anthony Therattil, Laura M Periman, et al.
BMC Ophthalmology|October 8, 2024
Efficacy and safety of a lipid-containing artificial tear compared with a non-lipid containing tear: a randomized clinical trialEric Donnenfeld, Jade Coats, Krista Barbour, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 17, 2020
The Immunological Basis of Dry Eye Disease and Current Topical Treatment OptionsLaura M Periman, Victor L Perez, Daniel R Saban, et al.
Journal of Medical Economics|May 2, 2025
The patient journey and burden of disease in Demodex blepharitis in the United StatesLaura M Periman, Walter O Whitley, Sathi Maiti, et al.
Biology of Sex Differences|October 21, 2021
The roles of sex and gender in women's eye health disparities in the United StatesIrene O Aninye, Kathleen Digre, M Elizabeth Hartnett, et al.
Clinical Therapeutics|February 10, 2023
Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye DiseaseJames Katz, Laura M Periman, Sathi Maiti, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 17, 2021
Meibomian Gland Dysfunction: A Dermatological Perspective on Pathogenesis and Treatment OutlookPreeya K Gupta, Laura M Periman, Edward Lain, et al.
Ophthalmology and Therapy|July 18, 2026
Improvement in Visual-Tasking Daily Living Activities and Work Productivity in Patients with Dry Eye Disease: Integrated Analysis of COMET StudiesLaura M Periman, Cory J Lappin, Marguerite B McDonald, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 11, 2026
Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Dye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 StudyJosh Johnston, Richard Adler, Michelle Hessen, et al.
Pageof 3